45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
8,826
Insurances with rates
4
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 360.037225nannan | REVASC INIT FEM-POP ATHRMY | $201,557 | $120,934 | — | — | 15 |
| 360.037227nannan | REVASC INIT FEM-POP ATHRMY+STN | $91,278 | $54,767 | — | — | 15 |
| 33517430 | RAVULIZUMAB-CWVZ 1100MG/11ML | $71,148 | $56,918 | — | — | 17 |
| 278.0nanC1767nan | INTERSTIM II NEUROSTM SYS MEDT | $70,395 | $42,237 | — | — | 15 |
| 278.0nanC1882nan | ICD CRT-D ASSURA STJUD VAR | $67,244 | $40,346 | — | — | 15 |
| 360.037228nannan | REVASC INIT TIB-PERN PTA | $62,111 | $37,267 | — | — | 15 |
| 360.037226nannan | REVASC INIT FEM-POP STENT | $57,700 | $34,620 | — | — | 15 |
| 361.036837nannan | PRQ AV FSTL CRT UXTR SEP ACS | $55,418 | $33,251 | — | — | 15 |
| 361.036836nannan | PRQ AV FSTL CRTJ UXTR 1 ACS | $55,418 | $33,251 | — | — | 15 |
| 360.037232nannan | REVASC ADDL TIB-PERN PTA | $46,534 | $27,920 | — | — | 14 |
| 73072974 | POLATUZMB VEDTN-PIIQ 140MG/7ML | $41,375 | — | — | — | 15 |
| 73072975 | OCRELIZUMAB 300 MG/10 ML VIAL | $40,625 | — | — | — | 15 |
| 73072231 | AMMONUL 10% INJ VIAL | $39,551 | — | — | — | 14 |
| 319.081448nannan | HSP COMPLETE RECESSIVE EVAL | $38,584 | $23,150 | — | — | 15 |
| 360.037224nannan | REVASC INIT FEM-POP PTA | $36,238 | $21,743 | — | — | 15 |
| 360.037221nannan | REVASC INIT ILIAC STENT | $35,635 | $21,381 | — | — | 15 |
| 360.037220nannan | REVASC INIT ILIAC PTA | $33,849 | $20,309 | — | — | 15 |
| 636.0nanC9047nan | CAPLACIZUMAB (CABLIVI)11MG/1ML | $33,260 | $19,956 | — | — | 14 |
| 73072690 | CABAZITAXEL 60 MG/6 ML VL | $33,003 | — | — | — | 15 |
| 278.0nanC1776nan | STEM HUMERAL PRIMARY BIOMET | $31,452 | $18,871 | — | — | 45 |
| 278.0nanC2622nan | PROSTHESIS PENL 11MM COLO | $30,017 | $18,010 | — | — | 15 |
| 361.036225nannan | CATH PL SUBC/INN W VERT IM UNI | $28,162 | $16,897 | — | — | 15 |
| 360.037223nannan | REVASC ADDL ILIAC STENT | $27,179 | $16,307 | — | — | 14 |
| 73072644 | ATEZOLIZUMAB 1,200 MG/20 ML | $25,868 | — | — | — | 15 |
| 278.0nanC1764nan | RECORDER CARD INSRT MEDTRON | $25,317 | $15,190 | — | — | 15 |
| 33517185 | TRIKAFTA ORAL TAB 7DAY PACK | $24,222 | $19,378 | — | — | 14 |
| 73073238 | LNRETDE ACTTE BRND 120MG/0.5ML | $23,905 | — | — | — | 15 |
| 481.0nanC9606LD | PRQ PLC DES RVSC W AMI SNGL LD | $23,339 | $14,003 | — | — | 14 |
| 481.0nanC9606RC | PRQ PLC DES RVSC W AMI SNGL RC | $23,339 | $14,003 | — | — | 14 |
| 319.081229nannan | MICROARRAY ANALYSIS - SNP | $23,076 | $13,846 | — | — | 15 |
| 73072941 | CEMIPLIMAB-RWLC 350MG/7ML VIAL | $22,750 | — | — | — | 15 |
| 73072677 | BRENTUXIMAB VEDOTIN 50 MG/10ML | $22,318 | — | — | — | 15 |
| 404.078816nannan | TUMOR IMAGE PET/CT FULL BODY | $21,492 | $12,895 | — | — | 17 |
| 361.037193nannan | REMOVE IVC FILTER | $21,393 | $12,836 | — | — | 15 |
| 361.037238nannan | OPEN/PRQ PLC STENT VEIN 1ST | $21,300 | $12,780 | — | — | 17 |
| 360.037236nannan | OPEN /PRQ PLC STENT ARTERY 1ST | $21,300 | $12,780 | — | — | 17 |
| 73080207 | ALTEPLASE INJ 100 MG | $20,518 | — | — | — | 15 |
| 361.036252nannan | INS CATH REN ART 1ST ORD BI | $20,208 | $12,125 | — | — | 17 |
| 73073046 | DARATUMUMAB-HYALURNIDSE-1800MG | $19,745 | — | — | — | 15 |
| 360.036907nannan | ADD ON ANGIOPLASTY CENTRAL | $19,648 | $11,789 | — | — | 16 |
| 481.093461nannan | R&L HRT ART/VNT ANG W GRFT | $19,172 | $11,503 | — | — | 15 |
| 636.0nanJ2783nan | RASBURICASE 1.5MG VIAL | $18,986 | $11,392 | — | — | 15 |
| 636.0nanJ0565nan | ZINPLAVA 1000MG/40ML (25MG/ML) | $18,351 | $11,011 | — | — | 15 |
| 73072822 | NIVOLUMAB 240 MG/24 ML VIAL | $18,345 | — | — | — | 15 |
| 73072601 | LANREOTIDE ACETATE 120MG/.5 ML | $17,683 | — | — | — | 15 |
| 404.078815nannan | TUMOR IMAGE PET/CT SKULL-THIGH | $17,522 | $10,513 | — | — | 17 |
| 73073036 | TENECTEPLASE 50 MG VIAL | $17,512 | — | — | — | 15 |
| 73072860 | RAMUCIRUMAB 500 MG/50 ML VIAL | $17,333 | — | — | — | 15 |
| 73081566 | NATALIZUMAB INJ 300MG/15ML | $17,130 | — | — | — | 15 |
| 73072678 | OBINUTUZUMAB 1,000 MG/40 ML VL | $17,122 | — | — | — | 15 |
Showing top 50 of 8,826 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.